Related Experiment Video

Updated: Jul 9, 2026

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry
11:20

Site-Directed Immobilization of Bone Morphogenetic Protein 2 to Solid Surfaces by Click Chemistry

Published on: March 29, 2018

Chemotherapeutic bone-targeted bisphosphonate prodrugs with hydrolytic mode of activation

Rotem Erez1, Sharon Ebner, Bernard Attali

  • 1Department of Organic Chemistry, School of Chemistry, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel-Aviv University, Tel Aviv 69978, Israel.

Bioorganic & Medicinal Chemistry Letters
|December 7, 2007
PubMed

Insights

Researchers developed novel bone-targeting chemotherapeutic prodrugs using bisphosphonates. These prodrugs are designed for hydrolytic activation, enhancing drug delivery to osseous tissues for potential cancer therapy.

Area of Science:

  • Medicinal Chemistry
  • Biomaterials Science
  • Oncology

Background:

  • Osseous tissues present unique biological challenges for targeted therapies.
  • Developing effective drug delivery systems for bone is crucial for treating bone-related diseases.

Purpose of the Study:

  • To design and synthesize novel hydrolytically activated chemotherapeutic prodrugs.
  • To incorporate a bone-targeting moiety (bisphosphonate) into these prodrugs.
  • To enable targeted drug delivery to osseous tissues.

Main Methods:

  • Synthesis of two types of bisphosphonate-containing prodrugs.
  • One prodrug type utilizes an ester-labile linkage for drugs with hydroxy groups.
  • The second prodrug type uses a self-immolative linker and carbonate-labile linkage for drugs with amine groups.
  • Demonstration using camptothecin (hydroxy group) and tryptophan (amine group).

Main Results:

  • Both synthesized prodrugs exhibited significant binding to hydroxyapatite, the primary bone component.
  • Hydrolytic activation of the prodrugs was confirmed under physiological conditions.
  • Successful conjugation strategies were demonstrated for different drug functional groups.

Conclusions:

  • Bisphosphonate-conjugated prodrugs are effective for targeting osseous tissues.
  • Hydrolytic activation provides a mechanism for controlled drug release at the target site.
  • These prodrugs represent a promising strategy for bone-targeted chemotherapy.

Related Concept Videos

Prodrugs01:30

Prodrugs

Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...